Philips Respironics Issues Recall for Trilogy EVO and EV300 Ventilators Over Nebulizer Compatibility

What Happened

Philips Respironics (operating as Respironics Inc.) has issued a health product recall regarding the Trilogy EVO platform ventilators. The company is no longer permitting the use of non-pneumatic nebulizers, such as vibrating mesh nebulizers, with these devices. This decision follows reports of nebulized aerosol deposition on the internal flow sensor, which can compromise the safe operation of the equipment. This update serves as a follow-up to previous field safety notices (FSN 2025-CC-SRC-020 and FSN 2024-CC-SRC-013) regarding flow sensor issues.

Which Products Are Affected

The recall affects the following Trilogy EVO platform ventilators:

• Trilogy EVO: Model/Catalogue Number CA2110X12B
• Trilogy EV300: Model/Catalogue Number CA2200X12B
• Trilogy EVO O2: Included as part of the Trilogy EVO platform collective.

The affected products were manufactured by Respironics Inc., also trading as Philips RS North America LLC, located in Murrysville, Pennsylvania.

What You Should Do

Healthcare providers and consumers must immediately cease the use of non-pneumatic (vibrating mesh) nebulizers with the affected Trilogy EVO, Trilogy EVO O2, and Trilogy EV300 ventilators. Users should refer to the updated field safety notices provided by Philips Respironics to ensure the continued safe and compliant operation of the ventilators.

Why This Matters

This restriction is critical because aerosol deposition on the internal flow sensor can lead to device malfunction. Ensuring the integrity of the flow sensor is essential for the ventilator to provide accurate respiratory support to patients.

Source

For more information, visit the official Health Canada recall notice.